Skip to content
naulon
Get started
Not checkedNot checked for notices yet.

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response

Willis S. Bowman, Gabrielle A. Echt, Justin M. Oldham

Frontiers in Medicine · 2021

doi:10.3389/fmed.2021.680997 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References214

  1. 41.

    Prognostic Factors for Myositis-Associated Interstitial Lung Disease · 2014

  2. 87.

    MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis · 2008

  3. 138.

    Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study · 2017

  4. 151.

    Adjustment for index event bias in genome-wide association studies of subsequent events · 2019

  5. 163.

    The natural history of progressive fibrosing interstitial lung diseases · 2019

  6. 164.

    Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease · 2019

  7. 165.

    Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study · 2019

  8. 169.

    Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort · 2019

  9. 179.

    Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis · 2020

205 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.